Strata Critical Medical, Inc. - Class A Stock (SRTA)

CUSIP: 092667104

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Class A Stock
Shares outstanding
85,979,314
Total 13F shares
38,807,858
Share change
+1,193,058
Total reported value
$134,994,588
Put/Call ratio
20%
Price per share
$3.48
Number of holders
115
Value change
+$4,500,006
Number of buys
58
Number of sells
50

Quarterly Holders Quick Answers

What is CUSIP 092667104?
CUSIP 092667104 identifies SRTA - Strata Critical Medical, Inc. - Class A Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of SRTA - Strata Critical Medical, Inc. - Class A Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ARK Investment Management LLC
13F
Company
7.2%
6,212,921
$17,706,825 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
4.7%
4,023,039
$11,465,661 31 Mar 2024
13F
Sumitomo Mitsui Trust Group, Inc.
13F
Company
4.3%
3,678,974
$10,485,076 31 Mar 2024
13F
Amova Asset Management Americas, Inc.
13F
Company
4.3%
3,678,974
$10,448,286 31 Mar 2024
13F
VANGUARD GROUP INC
13F
Company
3.5%
2,967,500
$8,457,375 31 Mar 2024
13F
AWM Investment Company, Inc.
13F
Company
2.5%
2,136,378
$6,088,677 31 Mar 2024
13F
Uniplan Investment Counsel, Inc.
13F
Company
1.8%
1,507,817
$4,297,000 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.5%
1,286,957
$3,668,220 31 Mar 2024
13F
Northern Right Capital Management, L.P.
13F
Company
1.4%
1,200,868
$3,422,474 31 Mar 2024
13F
STATE STREET CORP
13F
Company
1.4%
1,173,458
$3,344,355 31 Mar 2024
13F
JPMORGAN CHASE & CO
13F
Company
1%
878,675
$2,504,224 31 Mar 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.88%
756,226
$2,155,244 31 Mar 2024
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.72%
616,644
$1,757,435 31 Mar 2024
13F
Tidal Investments LLC
13F
Company
0.7%
604,018
$1,721,451 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
0.56%
485,473
$1,383,598 31 Mar 2024
13F
Brandywine Global Investment Management, LLC
13F
Company
0.52%
446,800
$1,273,380 31 Mar 2024
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.45%
383,763
$1,093,724 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
mixed-class rows
1,026,720
mixed-class rows
$1,004,301 31 Mar 2024
13F
Seth J. Bacon
3/4/5
CEO, Trinity Air Medical
class O/S missing
340,785
$1,001,908 13 Jun 2024
GSA CAPITAL PARTNERS LLP
13F
Company
0.33%
283,724
$809,000 31 Mar 2024
13F
Bouvel Investment Partners, LLC
13F
Company
0.31%
268,967
$766,556 31 Mar 2024
13F
Deane Retirement Strategies, Inc.
13F
Company
0.3%
256,320
$729,093 31 Mar 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
mixed-class rows
2,468,848
mixed-class rows
$721,567 31 Mar 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.29%
246,519
$702,579 31 Mar 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.28%
244,700
$697,000 31 Mar 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.28%
240,510
$685,454 31 Mar 2024
13F
Quinn Opportunity Partners LLC
13F
Company
0.26%
227,427
$648,167 31 Mar 2024
13F
Intellectus Partners, LLC
13F
Company
0.25%
215,850
$615,172 31 Mar 2024
13F
David Zaslav
3/4/5
Director
class O/S missing
3,127,284
$562,911 22 Sep 2021
JANE STREET GROUP, LLC
13F
Company
0.22%
187,413
$534,127 31 Mar 2024
13F
Man Group plc
13F
Company
0.21%
178,694
$509,278 31 Mar 2024
13F
Bank of New York Mellon Corp
13F
Company
0.19%
161,614
$460,600 31 Mar 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.18%
157,738
$449,553 31 Mar 2024
13F
BARCLAYS PLC
13F
Company
0.18%
150,726
$429,569 31 Mar 2024
13F
Aspen Grove Capital, LLC
13F
Company
0.15%
125,000
$356,250 31 Mar 2024
13F
Invesco Ltd.
13F
Company
0.13%
112,911
$321,797 31 Mar 2024
13F
SHERBROOKE PARK ADVISERS LLC
13F
Company
0.12%
105,907
$301,835 31 Mar 2024
13F
UBS Group AG
13F
Company
mixed-class rows
101,927
mixed-class rows
$290,344 31 Mar 2024
13F
Allen Investment Management, LLC
13F
Company
0.12%
100,000
$285,000 31 Mar 2024
13F
GUGGENHEIM CAPITAL LLC
13F
Company
0.11%
95,661
$272,634 31 Mar 2024
13F
RHUMBLINE ADVISERS
13F
Company
0.1%
89,131
$254,015 31 Mar 2024
13F
Walleye Capital LLC
13F
Company
class O/S missing
2,156,666
$225,372 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.09%
77,712
$221,479 31 Mar 2024
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.08%
68,878
$196,302 31 Mar 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.08%
68,549
$195,365 31 Mar 2024
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.07%
64,127
$182,762 31 Mar 2024
13F
Virtu Financial LLC
13F
Company
0.07%
60,092
$171,000 31 Mar 2024
13F
HSBC HOLDINGS PLC
13F
Company
0.07%
57,333
$163,399 31 Mar 2024
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.06%
55,634
$158,557 31 Mar 2024
13F
STIFEL FINANCIAL CORP
13F
Company
0.06%
53,343
$152,029 31 Mar 2024
13F

Institutional Holders of Strata Critical Medical, Inc. - Class A Stock (SRTA) as of Q2 2024

As of 30 Jun 2024, Strata Critical Medical, Inc. - Class A Stock (SRTA) was held by 115 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,807,858 shares. The largest 10 holders included ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., BlackRock Inc., VANGUARD GROUP INC, AWM Investment Company, Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Northern Right Capital Management, L.P., and DIMENSIONAL FUND ADVISORS LP. This page lists 116 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
112
Q2 2024 holders
115
Holder diff
3
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.